A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer: A Gynecologic Oncology Group study-Reference-Cited by-同舟云学术

A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer®) in recurrent ovarian cancer: A Gynecologic Oncology Group study

Published:2006-11 Issue:2 Volume:103 Page:391-396
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Armstrong Deborah K.,Fleming Gini F.,Markman Maurie,Bailey Howard H.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference13 articles.

1. Cancer of the ovary;Cannistra;N. Engl. J. Med.,2004

2. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer;McGuire;N. Engl. J. Med.,1996

3. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer;Dedrick;Cancer Treat Rep.,1978

4. Intraperitoneal TAXOL (paclitaxel) in the management of ovarian cancer;Markman;Ann. Oncol.,1994

5. Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study;Markman;J. Clin. Oncol.,1992

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation;Journal of Controlled Release;2024-09

2. A Comprehensive Review on Current Treatments and Challenges Involved in the Treatment of Ovarian Cancer;Current Cancer Drug Targets;2024-02

3. Targeted Radium Alpha Therapy in the Era of Nanomedicine: In Vivo Results;International Journal of Molecular Sciences;2024-01-04

4. Insight into RNA-based Therapies for Ovarian Cancer;Current Pharmaceutical Design;2023-09

5. Physiological Pathway, diagnosis and nanotechnology based treatment strategies for ovarian Cancer: A review;Medicine in Omics;2023-06